Is there any potential link among caspase-8, p-p38 MAPK and bcl-2 in clear cell renal cell carcinomas? A comparative immunohistochemical analysis with clinical connotations

Diagnostic Pathology

Volumn 4, Issue 1, 2009, Pages

  Samaras, Vassilis ^a   Tsopanomichalou, Tsopanomichalou ^b   Arnaoutoglou, Christos ^c   Samaras, Efstathios ^a   Arnaoutoglou, Marianthi ^d   Poulias, Hercules ^a   Barbatis, Calypso ^a  

^a RED CROSS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61849084212     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-4-7     Document Type: Article

References (36)

1. Systemic therapy for renal cell carcinoma. RJ Motzer P Russo, J Urol 2000 163 2 408 417 10.1016/S0022-5347(05)67889-5 10647643
2. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma. I Kausch H Jiang B Thode, Eur Urol 2005 47 5 703 709 10.1016/j.eururo.2004.11.013 15826766
3. BCL-2 family members and the mitochondria in apoptosis. A Gross JM McDonnell SJ Korsmeyer, Genes Dev 1999 13 15 1899 1911 10.1101/gad.13.15.1899 10444588
4. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma. T Sejima I Miyagawa, Eur Urol 1999 35 3 242 248 10.1159/000019855 10072628
5. Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma. X Zhang I Takenaka, Urology 2000 56 3 510 515 10.1016/S0090-4295(00) 00645-2 10962335
6. Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients. T Itoi K Yamana V Bilim, Br J Cancer 2004 90 1 200 205 10.1038/sj.bjc.6601454 14710230
7. Caspase-8 sumoylation is associated with nuclear localization. L Besnault-Mascard C Leprince MT Auffredou, Oncogene 2005 24 20 3268 3273 10.1038/sj.onc.1208448 15782135
8. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage. U Ramp E Caliskan C Mahotka, Br J Cancer 2003 88 11 1800 1807 10.1038/sj.bjc.6600984 12771998
9. Enhancement of death receptor 4 mediated apoptosis and cytotoxicity in renal cell carcinoma cells by subtoxic concentrations of doxorubicin. X Jin XX Wu MA Abdel-Muneem Nouh, J Urol 2007 177 5 1894 1899 10.1016/j.juro.2007.01.018 17437844
10. Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC. S Heikaus T Kempf C Mahotka, Apoptosis 2008 13 7 938 949 10.1007/s10495-008- 0225-6 18516683
11. Induction of apoptosis in renal cell carcinoma by reactive oxygen species: involvement of extracellular signal-regulated kinase 1/2, p38delta/gamma, cyclooxygenase-2 down-regulation, and translocation of apoptosis-inducing factor. M Ambrose A Ryan GC O'Sullivan, Mol Pharmacol 2006 69 6 1879 1890 10.1124/mol.105.020875 16543392
12. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. D Huang Y Ding WM Luo, Cancer Res 2008 68 1 81 88 10.1158/0008-5472.CAN-07-5311 18172299
13. The INK4a/ARF locus: role in cell cycle control for renal cell epithelial tumor growth after the Chernobyl accident. A Romanenko L Morell-Quadreny JA Lopez-Guerrero, Virchows Arch 2004 445 3 298 304 10.1007/s00428-004-1056-7 15232742
14. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. MA Cahill ME Peter FC Kischkel, Oncogene 1996 13 10 2087 2096 8950975
15. The p38 signal transduction pathway: activation and function. K Ono J Han, Cell Signal 2000 12 1 1 13 10.1016/S0898-6568(99)00071-6 10676842
16. Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. M Torcia G De Chiara L Nencioni, J Biol Chem 2001 276 42 39027 39036 10.1074/jbc.M102970200 11495898
17. p38 Mitogen-activated protein kinases is required for counteraction of 2-methoxyestradiol to estradiol-stimulated cell proliferation and induction of apoptosis in ovarian carcinoma cells via phosphorylation Bcl-2. SZ Bu Q Huang YM Jiang, Apoptosis 2006 11 3 413 425 10.1007/s10495-006-4064-z 16538384
18. Prognostic significance of morphologic parameters in renal cell carcinoma. SA Fuhrman LC Lasky C Limas, Am J Surg Pathol 1982 6 7 655 663 7180965
19. LH Sobin CH Wittekind, TNM Classification of Malignant Tumors New York: Wiley-Liss 6 2002
20. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. KH Tsui O Shvarts RB Smith, J Urol 2000 163 4 1090 1095 10.1016/S0022-5347(05)67699-9 10737472
21. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy. DP Zubac L Bostad C Gestblom, Scand J Urol Nephrol 2007 41 3 191 197 10.1080/00365590601016552 17469026
22. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. M Vakkala P Pääkkö Y Soini, Br J Cancer 1999 81 4 592 599 10.1038/sj.bjc.6690735 10574243
23. Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry. J Shen C Behrens II Wistuba, Cancer Res 2006 66 23 11194 11206 10.1158/0008-5472.CAN-04-1444 17145864
24. Proliferation and apoptosis in proliferative lesions of the colon and rectum. Y Kikuchi WN Dinjens FT Bosman, Virchows Arch 1997 431 2 111 117 10.1007/s004280050076 9293892
25. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. CS Mitsiades V Poulaki G Fanourakis, Clin Cancer Res 2006 12 12 3705 3712 10.1158/1078-0432.CCR-05-2493 16778096
26. Involvement of p38 MAP kinase in apoptotic and proliferative alteration in human colorectal cancers. H Miki H Yamada K Mitamura, Anticancer Res 1999 19 6B 5283 5291 10697550
27. MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival. T Demuth LB Reavie JL Rennert, Mol Cancer Ther 2007 6 4 1212 1222 10.1158/1535-7163.MCT- 06-0711 17406030
28. Bone morphogenetic protein 6 inhibit stress-induced breast cancer cells apoptosis via both Smad and p38 pathways. J Du S Yang Z Wang, J Cell Biochem 2008 103 5 1584 1597 10.1002/jcb.21547 17879955
29. Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. P Lipponen M Eskelinen K Syrjänen, Br J Cancer 1995 71 4 863 867 7710955
30. Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci. RH Pierce ME Vail L Ralph, Am J Pathol 2002 160 5 1555 1560 12000706
31. Bcl-2 expression on fine-needle aspirates from primary breast carcinoma: correlation with other biologic factors. C Bozzetti R Nizzoli N Naldi, Cancer 1999 87 4 224 230
32. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. H Ishida K Irie T Itoh, Cancer 1997 80 6 1034 1045
33. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. P Juo CJ Kuo J Yuan, Curr Biol 1998 8 18 1001 1008 10.1016/S0960-9822(07)00420-4 9740801
34. Bisindolylmaleimide VIII enhances DR5-mediated apoptosis through the MKK4/JNK/p38 kinase and the mitochondrial pathways. T Ohtsuka T Zhou, J Biol Chem 2002 277 32 29294 29303 10.1074/jbc.M203342200 12034736
35. Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells. T Abdollahi NM Robertson A Abdollahi, Apoptosis 2005 10 6 1383 1393 10.1007/s10495-005-2139-x 16215677
36. p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. M Alvarado-Kristensson F Melander K Leandersson, J Exp Med 2004 199 4 449 458 14970175 10.1084/jem.20031771